Evidence map›Paper›PMID 38876107›Full record

ArticleCell2024

An atlas of human vector-borne microbe interactions reveals pathogenicity mechanisms.

Thomas M Hart, Nicole D Sonnert, Xiaotian Tang, Reetika Chaurasia, Paige E Allen, Jason R Hunt, Curtis B Read, Emily E Johnson, Gunjan Arora, Yile Dai and 25 more

Abstract read
In one paragraph

Article in Cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. mBio · 2026
    Article
  4. Frontiers in pharmacology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. CCL17 Influences Borrelia burgdorferi Infection in the Heart.The Journal of infectious diseases · 2025
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Thomas M HartDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
Nicole D SonnertDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA; Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT 06510, USA.
Xiaotian TangDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
Reetika ChaurasiaDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
Paige E AllenDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
Jason R HuntDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
Curtis B ReadDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
Emily E JohnsonDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Department of Epidemiology and Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
Gunjan AroraDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
Yile DaiDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA.
Yingjun CuiDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
Yu-Min ChuangDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
Qian YuDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
M Sayeedur RahmanDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
M Tays MendesDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Agustin RolandelliDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Pallavi SinghDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
Abhai K TripathiW. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Choukri Ben MamounDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT 06510, USA.
Melissa J CaimanoDepartment of Medicine, UConn Health, Farmington, CT 06030, USA; Department of Pediatrics, UConn Health, Farmington, CT 06030, USA; Department of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA.
Justin D RadolfDepartment of Medicine, UConn Health, Farmington, CT 06030, USA; Department of Pediatrics, UConn Health, Farmington, CT 06030, USA; Department of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA; Department of Immunology, UConn Health, Farmington, CT 06030, USA.
Yi-Pin LinDivision of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12201, USA.
Volker FingerleBavarian Health and Food Safety Authority, Oberschleißheim, Munich 85764, Bavaria, Germany.
Gabriele MargosBavarian Health and Food Safety Authority, Oberschleißheim, Munich 85764, Bavaria, Germany.
Utpal PalDepartment of Veterinary Medicine, University of Maryland, College Park, MD 20742, USA.
Raymond M JohnsonDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT 06510, USA.
Joao H F PedraDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Abdu F AzadDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Jeanne SaljeDepartment of Pathology, University of Cambridge, Cambridge CB2 1TN, UK; Department of Biochemistry, University of Cambridge, Cambridge CB2 1TN, UK.
George DimopoulosW. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Joseph M VinetzDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Laboratorio ICEMR-Amazonia, Laboratorios de Investigación Y Desarrollo, Facultad de Ciencias Y Filosofia, Universidad Peruana Cayetano Heredia, Lima 15102, Peru; Instituto de Medicina Tropical Alexander Von Humboldt, Universidad Peruana Cayetano Heredia, Lima 15102, Peru.
Jason A CarlyonDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA. Electronic address: jason.carlyon@vcuhealth.org.
Noah W PalmDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA. Electronic address: noah.palm@yale.edu.
Erol FikrigDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA. Electronic address: erol.fikrig@yale.edu.
Aaron M RingTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98102, USA. Electronic address: aaronring@fredhutch.org.

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Renato Martins · 1985 to 2026
$51.0M
Tick Resources CoreP01AI138949 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI Erol Fikrig · 2018 to 2026
$13.5M
RpoS Regulation of Borrelia burgdorferi Genes in vivoR01AI029735 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI CAIMANO, MELISSA J, RADOLF, JUSTIN D · 1990 to 2022
$10.7M
MURINE TYPHUS: VECTOR BIOLOGY AND TRANSMISSIONR01AI017828 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI RAHMAN, MOHAMMED SAYEEDUR · 1985 to 2022
$10.2M
IMMUNOHEMATOLOGY/TRANSFUSION MEDICINE RESEARCH TRAININGT32HL007974 · NHLBI · YALE UNIVERSITY · PI JEANNE E HENDRICKSON, Diane S Krause · 2001 to 2026
$8.1M
Rickettsia-host interface and multiple paths to invasionR01AI126853 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Mohammed Sayeedur Rahman, Oliver Voss · 2016 to 2026
$6.9M
Ubiquitylation and Rickettsial Colonization of a Tick VectorR01AI116523 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PEDRA, JOAO · 2016 to 2025
$6.2M
The roles of ceramide and its derivatives in A. phagocytophilum pathogenesisR01AI139072 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHARLES E. CHALFANT, Jason A Carlyon · 2018 to 2026
$5.7M
Tick Saliva and Pathogen TransmissionR01AI134696 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Joao Pedra · 2018 to 2026
$5.1M
Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of miceR01AI158615 · NIAID · YALE UNIVERSITY · PI DIMOPOULOS, GEORGE, FIKRIG, EROL · 2021 to 2025
$4.1M
Fosinopril analogs for the treatment of human babesiosisR01AI153100 · NIAID · YALE UNIVERSITY · PI BEN MAMOUN, CHOUKRI · 2021 to 2025
$3.6M
Predicting Risk of Human Leptospiros by Environmental SurveillanceR01AI108276 · NIAID · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2013 to 2017
$3.6M
NCI NIH HHS P30 CA016059NHLBI NIH HHS T32 HL007974NIAID NIH HHS F32 AI174656NIAID NIH HHS P01 AI138949NIAID NIH HHS R01 AI017828NIAID NIH HHS R01 AI029735NIAID NIH HHS R01 AI108276NIAID NIH HHS R01 AI116523NIAID NIH HHS R01 AI126853NIAID NIH HHS R01 AI134696NIAID NIH HHS R01 AI139072NIAID NIH HHS R01 AI152220NIAID NIH HHS R01 AI153100NIAID NIH HHS R01 AI158615NIAID NIH HHS R01 AI165499NIAID NIH HHS R01 AI167857NIAID NIH HHS R21 AI173921NIAID NIH HHS R21 AI187932NIAID NIH HHS R37 AI017828NIAID NIH HHS R37 AI072683NIAID NIH HHS U19 AI115658NIH HHS S10 OD030363
6 · The paper itself

Abstract

Vector-borne diseases are a leading cause of death worldwide and pose a substantial unmet medical need. Pathogens binding to host extracellular proteins (the "exoproteome") represents a crucial interface in the etiology of vector-borne disease. Here, we used bacterial selection to elucidate host-microbe interactions in high throughput (BASEHIT)-a technique enabling interrogation of microbial interactions with 3,324 human exoproteins-to profile the interactomes of 82 human-pathogen samples, including 30 strains of arthropod-borne pathogens and 8 strains of related non-vector-borne pathogens. The resulting atlas revealed 1,303 putative interactions, including hundreds of pairings with potential roles in pathogenesis, including cell invasion, tissue colonization, immune evasion, and host sensing. Subsequent functional investigations uncovered that Lyme disease spirochetes recognize epidermal growth factor as an environmental cue of transcriptional regulation and that conserved interactions between intracellular pathogens and thioredoxins facilitate cell invasion. In summary, this interactome atlas provides molecular-level insights into microbial pathogenesis and reveals potential host-directed targets for next-generation therapeutics.

Indexed as

Host-Pathogen InteractionsAnimalsBorrelia burgdorferiHost Microbial InteractionsHumansLyme DiseaseVector Borne Diseasesarthropod-borne diseasehost-pathogen interactionshost sensinginfectious diseaseLyme diseasemechanisms of pathogenicityprotein disulfide isomerasesystems biologythioredoxinvector-borne disease

Identifiers

PMID38876107
PMCPMC11959484

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.